Paper3933869
Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation.
Stohl W. Clin Exp Immunol, 1985. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation. Papers, record 3933869. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3933869
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulation of the immune response by immunoglobulin for intravenous use. I. Inhibition of pokeweed mitogen-induced B cell differentiation.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B-Lymphocytes | Major topic |
| Immune Tolerance | Major topic |
| Immunoglobulin G | Major topic |
| Lymphocyte Activation | Major topic |
| Pokeweed Mitogens | Major topic |
| Antibody-Producing Cells | |
| Culture Media | |
| Hemolytic Plaque Technique | |
| Humans | |
| Immunoglobulin Fab Fragments | |
| Immunoglobulins, Intravenous | |
| Kinetics |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5T32 GM-07245-10 | NIGMS NIH HHS | United States | T32GM072451 | PubMed | NIH RePORTER |
| AI 10811 | NIAID NIH HHS | United States | R01AI010811 | PubMed and NIH | NIH RePORTER |
| AM 04761 | NIADDK NIH HHS | United States | R01AM004761 | PubMed and NIH | NIH RePORTER |
| T32GM007245 | NIH | NIH RePORTER |
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 182,899 | Fc receptor-mediated inhibition of murine B-lymphocyte activation. | J Exp Med | 1976 | https://conductscience.org/library/papers/182899 | PubMed |
| 2 | 13,864,762 | Intravenous administration of human gamma-globulin. | Vox Sang | 1962 | https://conductscience.org/library/papers/13864762 | PubMed |
| 3 | 301,544 | Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. | J Exp Med | 1977 | https://conductscience.org/library/papers/301544 | PubMed |
| 4 | 302,794 | The role of the Fc receptor (FcR) of thymus-derived lymphocytes. II. Presence of FcR on suppressor cells and direct involvement in suppression. | Eur J Immunol | 1977 | https://conductscience.org/library/papers/302794 | PubMed |
| 5 | 355,125 | Direct blockade of antigen-reactive B lymphocytes by immune complexes. An 'off' signal for precursors of IgM-producing cells provided by the linkage of antigen-and Fc-receptors. | Immunology | 1978 | https://conductscience.org/library/papers/355125 | PubMed |
| 6 | 363,283 | Fc receptor dependency of antibody mediated feedback regulation: on the mechanism of inhibition. | Cell Immunol | 1978 | https://conductscience.org/library/papers/363283 | PubMed |
| 7 | 312,853 | Human B cell differentiation. II. Suppression by T cells of T-dependent and T-independent plasma cell maturation. | J Immunol | 1979 | https://conductscience.org/library/papers/312853 | PubMed |
| 8 | 6,966,197 | Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. | Clin Immunol Immunopathol | 1980 | https://conductscience.org/library/papers/6966197 | PubMed |
| 9 | 6,162,859 | Dysfunctions of pokeweed mitogen-stimulated T and B lymphocyte responses induced by gammaglobulin therapy. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6162859 | PubMed |
| 10 | 6,112,565 | High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. | Lancet | 1981 | https://conductscience.org/library/papers/6112565 | PubMed |
| 11 | 6,456,302 | Suppression of the late stages of mitogen-induced human B cell differentiation by FC gamma receptors (FC gamma R) released from polymorphonuclear neutrophils. | J Immunol | 1981 | https://conductscience.org/library/papers/6456302 | PubMed |
| 12 | 6,172,514 | Feedback regulation of immune responses by immune complexes; possible involvement of a suppressive lymphokine by FcR gamma-bearing B cell. | J Immunol | 1982 | https://conductscience.org/library/papers/6172514 | PubMed |
| 13 | 6,977,944 | Characterization of various immunoglobulin preparations for intravenous application. I. Protein composition and antibody content. | Vox Sang | 1982 | https://conductscience.org/library/papers/6977944 | PubMed |
| 14 | 6,803,159 | Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. | N Engl J Med | 1982 | https://conductscience.org/library/papers/6803159 | PubMed |
| 15 | 6,191,803 | Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. | Blood | 1983 | https://conductscience.org/library/papers/6191803 | PubMed |
| 16 | 6,193,913 | Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6193913 | PubMed |
| 17 | 6,228,600 | Modulation of mononuclear phagocyte function by intravenous gamma-globulin. | J Immunol | 1984 | https://conductscience.org/library/papers/6228600 | PubMed |
| 18 | 6,611,368 | Regulation of antibody release by naturally occurring anti-immunoglobulins in cultures of pokeweed mitogen-stimulated human peripheral blood lymphocytes. | J Immunol | 1984 | https://conductscience.org/library/papers/6611368 | PubMed |
| 19 | 6,332,371 | Modulation of pokeweed mitogen-induced human B-cell differentiation by aggregated IgG. | Scand J Immunol | 1984 | https://conductscience.org/library/papers/6332371 | PubMed |
| 20 | 6,206,756 | Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. | Ann Intern Med | 1984 | https://conductscience.org/library/papers/6206756 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,059,993 | Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells? | Clin Exp Immunol | 2011 | https://conductscience.org/library/papers/22059993 | PubMed |
| 19,737,236 | Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production. | Clin Exp Immunol | 2009 | https://conductscience.org/library/papers/19737236 | PubMed |
| 7,523,434 | Modulation of immunoglobulin production and cytokine mRNA expression in peripheral blood mononuclear cells by intravenous immunoglobulin. | J Clin Immunol | 1994 | https://conductscience.org/library/papers/7523434 | PubMed |
| 3,501,745 | Inhibition of T cell-dependent human B cell proliferation and B cell differentiation by polyspecific monomeric IgG. | Clin Exp Immunol | 1987 | https://conductscience.org/library/papers/3501745 | PubMed |
| 2,565,412 | Immunomodulating therapy of rheumatoid arthritis by high-dose intravenous immunoglobulin. | Klin Wochenschr | 1989 | https://conductscience.org/library/papers/2565412 | PubMed |
| 2,433,307 | Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin. | J Clin Invest | 1987 | https://conductscience.org/library/papers/2433307 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3933869
GET https://conductscience.org/api/papers/v1/3933869/references?page=2